Cargando…
The clinical and functional significance of c-Met in breast cancer: a review
c-Met is a receptor tyrosine kinase that upon binding of its ligand, hepatocyte growth factor (HGF), activates downstream pathways with diverse cellular functions that are important in organ development and cancer progression. Anomalous c-Met signalling has been described in a variety of cancer type...
Autores principales: | Ho-Yen, Colan M, Jones, J Louise, Kermorgant, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389345/ https://www.ncbi.nlm.nih.gov/pubmed/25887320 http://dx.doi.org/10.1186/s13058-015-0547-6 |
Ejemplares similares
-
Comment on ‘High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer'
por: Ho-Yen, C, et al.
Publicado: (2013) -
c-Met-integrin cooperation: Mechanisms, tumorigenic effects, and therapeutic relevance
por: Stanislovas, Justas, et al.
Publicado: (2022) -
The role of MET in chemotherapy resistance
por: Wood, Georgina E., et al.
Publicado: (2021) -
The Role of PI3K in Met Driven Cancer: A Recap
por: Hervieu, Alexia, et al.
Publicado: (2018) -
Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation
por: Kermorgant, Stéphanie, et al.
Publicado: (2008)